Publication | Closed Access

Thalidomide decreases the plasma levels of IL-1 and TNF following burn injury: Is it a new drug for modulation of systemic inflammatory response

InflammationNew DrugAnti-inflammatoryMedicineImmunologyChronic InflammationSepsisInflammatory MarkerBurn ManagementBurn InjuryPharmacotherapySystemic Inflammatory ResponsePharmacologyInflammatory DiseaseRheumatoid Arthritis